Ergenc, I. And YILMAZ, Y. 2024. Letter: Metabolic Dysfunction–Associated Steatotic Liver Disease in Primary Biliary Cholangitis—Friend, Foe or Red Herring?. Alimentary Pharmacology and Therapeutics .

Ergenc, I., & YILMAZ, Y., (2024). Letter: Metabolic Dysfunction–Associated Steatotic Liver Disease in Primary Biliary Cholangitis—Friend, Foe or Red Herring?. Alimentary Pharmacology and Therapeutics .

Ergenc, Ilkay, And YUSUF YILMAZ. "Letter: Metabolic Dysfunction–Associated Steatotic Liver Disease in Primary Biliary Cholangitis—Friend, Foe or Red Herring?," Alimentary Pharmacology and Therapeutics , 2024

Ergenc, Ilkay And YILMAZ, YUSUF. "Letter: Metabolic Dysfunction–Associated Steatotic Liver Disease in Primary Biliary Cholangitis—Friend, Foe or Red Herring?." Alimentary Pharmacology and Therapeutics , 2024

Ergenc, I. And YILMAZ, Y. (2024) . "Letter: Metabolic Dysfunction–Associated Steatotic Liver Disease in Primary Biliary Cholangitis—Friend, Foe or Red Herring?." Alimentary Pharmacology and Therapeutics .

@article{article, author={Ilkay Ergenc And author={YUSUF YILMAZ}, title={Letter: Metabolic Dysfunction–Associated Steatotic Liver Disease in Primary Biliary Cholangitis—Friend, Foe or Red Herring?}, journal={Alimentary Pharmacology and Therapeutics}, year=2024}